InsidersTradesSigma
康华生物 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 康华生物 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 康华生物 has logged 12 public disclosures. Market capitalisation: €9.4bn. The latest transaction was disclosed on 21 November 2023 (Sale). Among the most active insiders: 三明玖日广隶商贸合伙企业(有限合伙). Every trade is openly available.
12
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
12 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,972 of 25,619 companies
63.1
score / 100
Value49
Quality78
FCF yld4.9%
Earn yld3.5%
EV/EBITDA18.9x
ROE6.4%
Gross mgn92%
Net mgn19%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 21 November 2023
Declarations12 total
425,635 sharesA股XSHESZSE:173000004751923070
425,635 sharesA股XSHESZSE:173000004751933100
425,635 sharesA股XSHESZSE:173000004751936500
425,635 sharesA股XSHESZSE:173000004751941820
425,635 sharesA股XSHESZSE:173000004751926200
425,635 sharesA股XSHESZSE:173000004751929250
12 of 12 declarations